- Home
- SDOT vs TRAW Comparison
SDOT vs TRAW Comparison
Compare SDOT & TRAW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SDOT
- TRAW
- Stock Information
- Founded
- SDOT 2014
- TRAW 1998
- Country
- SDOT United States
- TRAW United States
- Employees
- SDOT N/A
- TRAW N/A
- Industry
- SDOT Restaurants
- TRAW
- Sector
- SDOT Consumer Discretionary
- TRAW
- Exchange
- SDOT Nasdaq
- TRAW NYSE
- Market Cap
- SDOT 8.0M
- TRAW 7.8M
- IPO Year
- SDOT 2020
- TRAW 2013
- Fundamental
- Price
- SDOT $1.19
- TRAW $1.65
- Analyst Decision
- SDOT
- TRAW
- Analyst Count
- SDOT 0
- TRAW 0
- Target Price
- SDOT N/A
- TRAW N/A
- AVG Volume (30 Days)
- SDOT 75.9K
- TRAW 3.5M
- Earning Date
- SDOT 05-14-2025
- TRAW 05-15-2025
- Dividend Yield
- SDOT N/A
- TRAW N/A
- EPS Growth
- SDOT N/A
- TRAW N/A
- EPS
- SDOT 1.07
- TRAW N/A
- Revenue
- SDOT $726,598,000.00
- TRAW $227,000.00
- Revenue This Year
- SDOT $12.76
- TRAW $3.81
- Revenue Next Year
- SDOT $5.54
- TRAW $30.43
- P/E Ratio
- SDOT $1.10
- TRAW N/A
- Revenue Growth
- SDOT 18.91
- TRAW 0.44
- 52 Week Low
- SDOT $1.12
- TRAW $0.97
- 52 Week High
- SDOT $7.00
- TRAW $19.44
- Technical
- Relative Strength Index (RSI)
- SDOT 33.39
- TRAW 54.15
- Support Level
- SDOT $1.16
- TRAW $1.30
- Resistance Level
- SDOT $1.25
- TRAW $2.58
- Average True Range (ATR)
- SDOT 0.09
- TRAW 0.23
- MACD
- SDOT 0.03
- TRAW 0.07
- Stochastic Oscillator
- SDOT 24.14
- TRAW 34.04
About SDOT Sadot Group Inc.
Sadot Group Inc operates in the food supply chain sector, connecting producers and consumers across the globe, delivering agri-commodities from producing geographies such as the Americas, Africa, and the Black Sea to consumer markets in Southeast Asia, China and the Middle East/North Africa (MENA) region. Its reportable segment includes Sadot food service and Sadot agri-foods. The key revenue is coming from the Sadot agri-foods segment which engaged in farming, commodity trading, and shipping of food and feed.
About TRAW TRAWS PHARMA INC
Traws Pharma Inc is a clinical-stage biopharmaceutical company dedicated to developing novel therapies to target critical threats to human health in respiratory viral diseases. It is advancing novel investigational antiviral agents that have potent activity against difficult-to-treat or resistant virus strains that threaten human health. Its product candidates are Tivoxavir marboxil, Ratutrelvir, and Narazaciclib.